Endless Advancement Towards a Global Natural Substance Research Bio Company
2013 ~ 2020
A Challenge Towards Cell Health, the Essential Cause of Chronic Diseases
2008 ~ 2012
The First Steps to Promote Healthy Lives with Natural Materials
2024.
02
Surpassed 2,500 Cellmed member pharmacies.
CEO Bong Keun Jang received a commendation at the 70th-anniversary ceremony of the Seoul Pharmacist Association.
Actress Kim Seong-ryeong was selected as an advertising model.
2023.
10
CEO Bong Keun Jang was awarded the Pharmaceutical Technology Award by the Korean Pharmaceutical Association.
08
Acquired 100% stake in pharmaceutical company InsPharm Korea. Publication of a related paper on the new drug candidate OPT-0139 in the International Journal of Molecular Sciences.
07
Launched in the US Market and established the first CellMed member pharmacy in Atlanta, USA.
05
CEO Bong Keun Jang was awarded TV Chosun's Korea's Influential CEO award.
2022.
12
Entered into agreement for practical training in the pharmaceutical industry with Woosuk University's College of Pharmacy
11
Participated in the 8th Pharmacy Academic Festival and the 28th PharmExpo, and lectured at the seminar on 'Innovative Paradigm of Clinical Nutrition Pharmacy OCNT'
Hosted cancer seminar featuring Dr. Eui Sin Kim as a guest speaker, tenured professor at MD Anderson.
10
Acquired patent on 'Non-narcotic Pain Relief Drug' in Japan.
Donated 4,000 Siabams to the Community Chest of Korea (Gyeonggi Love's Fruit)
09
Participated in the CellMed Gyeonggi Pharmaceutical Academic Conference and lectured at the seminar on 'Palmyunyukbi Broad-spectrum Natural Cancer Vaccine'
08
Participated in a social contribution event for heatwave preparedness kits for the vulnerable, organized by the Seoul Industry Promotion Agency
'Immuno-oncology Natural Nutrients AFNC & ABF' book launch event
Actress, Lee Sun-kyun was selected as an advertising model for TV commercials.
06
Participated in the Gyeongnam Changwon Pharm Expo and lectured at the seminar on 'Innovative Paradigm'.
05
10-week Pharmacy Management Academy with 'CellMed'
04
Expansion and relocation of JBKLAB's anticancer drug development research institute
Launch of CellMedi Food Research Institute
2022 Korea Luxury Brand Award
03
CellMed was awarded the Korea Premium Brand Award
2021.
12
CEO Bong Keun Jang presents at the K-Bio Health Forum (Importance of Medical Food) Merged with oncopharmatech, an anticancer drug development company
11
Surpassed 1,000 Cellmed member pharmacies.
10
Held Sunflower Seed Oil Radio Advertisement Slogan Contest
09
‘EuphaFelx Alpha’ was Selected as the Excellent SME Product of the Month by the Ministry of SMEs and Startups .
Obtained a confirmation letter for a venture company and technology innovation type small and medium-sized enterprise (inno-biz).
Established a second factory dedicated to producing oil products
Contracted with entertainer, Yang Hee-eun as a radio advertisement model
02
signed MOU with Gyeonggi Pharmaceutical Association.
01
Patent registration in Korea: 'Use of anthocyanin-negatively charged polysaccharide complex for prevention or treatment of influenza A virus infection'.
Patent registration in Korea: 'Pharmaceutical composition for prevention or treatment of aging or age-related diseases containing anthocyanin-polysaccharide complex as active ingredient'
CELLMED KCI issued by CellMed Cellular Correction Medicine was recognized and selected as a registered academic journal.
2020.
12
Entered into a agreement on 'Innovative Natural Substance Ulcerative Colitis Drug Development' with Oncopharmatech-Biotoxtech.
09
Publication of the book 'If the cell lives, so do you (Cell Correction and Improvement Reaction)'
08
"Mechanism and effect of AFNC on cancer prevention and growth inhibition" published in the SCI international journal, International Journal of Pharmaceutics
Appointment ceremony and InfoBox demonstration for the 2nd academic committee of the CellMed Cellular Correction Medicine Society
03
Participated in fundraising for love's fruit in Daegu to overcome the COVID-19 virus
2019.
11
“CellMed Cellular Correction Medicine Society” was designated as a candidate journal for registration by the National Research Foundation of Korea.
10
Appointment ceremony for the academic committee of the CellMed Cellular Correction Medicine Society.
10
Made business cooperation agreement for development of natural complex mineral products with EcoBiotech.
07
SiaPlex (SiaNox) registered with the U.S. FDA OTC
07
Cyaplex and Heartberry Black were selected for the 2019 Money Today Hit Product & Innovation Technology Award.
06
completed patent application of 'Use of anthocyanin-negatively charged polysaccharide complex for prevention or treatment of influenza A virus infection'
06
Completed patent application of 'Composition for prevention, improvement, or treatment of gastritis or peptic ulcer containing anthocyanin-negatively charged polysaccharide complex as an active ingredient'
02
entered into a patent technology transfer agreement for composition for prevention and treatment of aging diseases using anthocyanin-polysaccharide complex
01
Official launch of CellMed
2018.
12
completed patent application of 'Method for manufacturing liposomes containing aronia extract with improved formulation stability'
12
Completed patent application of 'Pharmaceutical composition for prevention or treatment of aging or age-related diseases containing anthocyanin-alginic acid complex as an active ingredient'
10
Acquisition of drug development specialist JC Pharma
09
completed PCT international patent application for 'immuno-enhancer, immuno-oncology agent, and anticancer agent side effect mitigator containing anthocyan in-fucoidan complex as an active ingredient'
09
Received the 2018 Medical Consumer Satisfaction Award
06
Certified as a technology innovation type small and medium-sized enterprise (inno-biz) by the Ministry of SMEs and Startups
01
Certified as an excellent technology evaluation company (T-4) by NICE Evaluation Information in 2018
2017.
12
Rresearch institute Registration
12
Received the Grand Prize in the Quality Innovation category at the 2018 Korea Innovation Awards
10
Selected as a family company by the Korea Basic Science Institute
09
signed contract with Samsung Securities as the lead managing underwriter for listing
Completed patent application for 'immuno-enhancer and immuno-oncology agent containing anthocyanin-fucoidan complex as an active ingredient'
09
Technology consultation contract on the anti-aging use of aronia extract with the Korea Basic Science Institute
06
Awarded the 2017 Medical Consumer Satisfaction Award in the anti-aging company category (2nd consecutive award)
01
Certified as an excellent investment technology evaluation company (TI-4, Excellent) by NICE Evaluation Information
2016.
10
signed agreement with the Industry-University Cooperation Foundation of The Catholic University of Korea for development of anthocyanin-fucoidan complex manufacturing and anticancer adjuvant
05
Obtained HACCP certification for vegetable juice
2015.
12
Merger with JBKLAB's Institute of Natural Medicine
06
Company name change to JBKLAB
03
Registration of patent: 'Composition for prevention and treatment of non-alcoholic fatty liver disease'
2014.
02
Registration of patent: 'Anthocyanin complex using negatively charged polysaccharides, composition containing it, and its manufacturing method' patent registered
2013.
03
Registration of patent: 'Pharmaceutical composition for prevention and treatment of arteriosclerosis and hypertension containing aronia bioactive fraction C3G complex as an active ingredient'.
03
Registration of patent: 'Composition for diabetes containing plant mixture extract'
2010.
05
Registration of patent: 'Composition for inducing cellular aging and method for inducing cellular aging using phenyl 2-pyridyl ketoxime as an active ingredient'.
03
Business registration (food manufacturing and processing) / Business notification (food sub-packaging sale)
01
Made joint research agreement on aronia extract with Kyung Hee University's Institute of Oriental Medicine
Registration of patent: '(R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol as an active ingredient containing composition for inducing cellular aging and method for inducing cellular aging using it'
2008.
12
Made clinical agreement on hypertension and arteriosclerosis with Samsung Medical Center
